Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Enuzovimab

(Synonyms: HFB-30132A, ABL-901) Copy Product Info
🥰Excellent

Synonyms: HFB-30132A, ABL-901

Catalog No. T9901A-095 Copy Product Info
🥰Excellent
Enuzovimab is a human-derived IgG4κ monoclonal antibody targeting SARS-CoV-2. The isotype control for Enuzovimab is HumanIgG4(S228P) kappa, Isotype Control.
Enuzovimab
Cas No. 2531098-91-4
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$2564-6 weeks4-6 weeks
5 mg$7684-6 weeks4-6 weeks
10 mg$1,2204-6 weeks4-6 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Enuzovimab is a human-derived IgG4κ monoclonal antibody targeting SARS-CoV-2. The isotype control for Enuzovimab is HumanIgG4(S228P) kappa, Isotype Control.
SynonymsHFB-30132A, ABL-901
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
TargetSARS-CoV-2
Chemical Properties
Cas No.2531098-91-4
Storage & Solubility Information
Storage-20°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion
Related Tags: